TD Cowen 44th AnnualHealth Care Conference . Fireside chat onMonday, March 4, 2024 at11:10 a.m. ET inBoston, MA. Leerink Global Biopharma Conference . Fireside chat onMonday, March 11, 2024 at2:40 p.m. ET inMiami, FL. Barclays Global Healthcare Conference . Fireside chat onTuesday, March 12, 2024 at3:35 p.m. ET inMiami, FL.
Additional information regarding these events will be available on the Investors section of the argenx website at argenx.com/investors.
About argenx
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) blocker in the
For further information, please contact:
Media:
bpetok@argenx.com
Investors:
aroy@argenx.com
lelton@argenx.com
Source: argenx SE
2024 GlobeNewswire, Inc., source